XT
XTL Biopharmaceuticals Ltd.
XTLB.TA · TLV
1.80 ILA -5.26% (-0.10 ILA)
1M -5.00%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
28 /100
Declining Book val. growth 0.63%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
Asset turnover N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Debt/Assets N/A
Stability
57 /100
Moderate Beta 0.55x
Profitable years 0
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XTLB.TA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Noam Band
Employees
10
Headquarters
Herzliya